1-Phenylpyrrole

CAS No. 635-90-5

1-Phenylpyrrole( NSC 16581 | NSC-16581 | NSC16581 )

Catalog No. M27262 CAS No. 635-90-5

1-Phenylpyrrole is an inhibitor of CYP450 dependant monooxygenase activity in microsomes from rat liver.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 28 In Stock
100MG Get Quote In Stock
200MG 27 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    1-Phenylpyrrole
  • Note
    Research use only, not for human use.
  • Brief Description
    1-Phenylpyrrole is an inhibitor of CYP450 dependant monooxygenase activity in microsomes from rat liver.
  • Description
    1-Phenylpyrrole is an inhibitor of CYP450 dependant monooxygenase activity in microsomes from rat liver.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    NSC 16581 | NSC-16581 | NSC16581
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    635-90-5
  • Formula Weight
    143.189
  • Molecular Formula
    C10H9N
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    c1ccn(c1)-c1ccccc1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Uehara W, Yoshida S, Emaya Y, Fuchigami T, Haratake M, Nakayama M. Selenoprotein L-inspired nano-vesicular peroxidase mimics based on amphiphilic diselenides. Colloids Surf B Biointerfaces. 2018 Feb 1;162:172-178. doi: 10.1016/j.colsurfb.2017.11.063. Epub 2017 Nov 26. PubMed PMID: 29190468.
molnova catalog
related products
  • Gly-Hyp|H-Gly-Hyp-OH

    Gly-Hyp|H-Gly-Hyp-OH

  • Nequinate

    Nequinate is an anticoccidial agent preventing coccidiosis .

  • Nogo-66 (1-40)

    Peptide fragment corresponding to residues 1 - 40 of Nogo-66, the domain of the myelin protein Nogo that inhibits axonal outgrowth. Acts as a competitive antagonist at the Nogo-66 receptor (NgR); blocks Nogo-66- and CNS myelin-induced inhibition of axonal growth, but does not reduce myelin-associated glycoprotein (MAG) inhibition of neurite outgrowth in vitro. Promotes regeneration of hemisected spinal axons and locomotor recovery following spinal injury in vivo.